Related Experiment Video
Updated: Jul 2, 2026

Intravitreous Injection for Establishing Ocular Diseases Model
Published on: October 1, 2007
Macular Toxicity Following Intravitreal Clindamycin: A Case Report and Literature Review
Sahba Fekri1,2, Shahriyar Shafa3, Amin Zand3
1Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Intravitreal clindamycin injection for ocular toxoplasmosis can cause severe retinal toxicity, including macular infarction. This rare complication leads to significant vision loss and necessitates careful consideration of treatment risks.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacology
Background:
- Ocular toxoplasmosis is a significant cause of retinitis.
- Intravitreal injections are used to treat ocular inflammation.
- Clindamycin is an antibiotic sometimes used off-label for ocular infections.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Cardiomyopathy II: Dilated Cardiomyopathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Yellow Fever
Diabetic Retinopathy

